MLSS חוב כולל להון Milestone Scientific Inc.

Milestone Scientific (MLSS) serves as a technological leader in precision anesthesia administration utilizing Wand/STA AI systems. This price chart on the GURU.Markets platform shows that the debt-to-equity ratio is 0.19. The company faces a liquidity shortage due to inertia in the dental market, while its developments support environmental sustainability by minimizing pharmaceutical waste.

To objectively assess the stability of Milestone Scientific (MLSS), investors must compare capital growth rates with the volume of debt obligations. Analyzing the company's history of debt leverage reveals the ratio of total debt to equity, which, combined with recurring revenue from the sale of consumables, confirms the business's ability to service loans through a stable free cash flow.